BILIARY TRACT CARCINOMA
Clinical trials for BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple therapy shows promise against hard-to-treat bile duct cancer
Disease control Recruiting nowThis study tests a combination of three treatments—chemotherapy (GEMOX), a targeted drug (Donafenib), and an immunotherapy (Tislelizumab)—in people with advanced biliary tract cancer that has spread. The goal is to see if this mix can shrink tumors and improve survival. About 93 …
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 02:15 UTC
-
Promising 4-Drug cocktail targets Hard-to-Treat bile duct cancer
Disease control Recruiting nowThis study tests a combination of four drugs (gemcitabine, cisplatin, zimberelimab, and quemliclustat) as a first treatment for people with advanced bile duct cancer that has not spread or come back after prior therapy. About 33 to 39 participants will receive the drugs in cycles…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Nataliya Uboha • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug AZD8205 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called AZD8205, alone or with other cancer drugs, for people with advanced solid tumors like breast, ovarian, or lung cancer that have stopped responding to standard treatments. The main goals are to check safety and find the right dose. About 460 adul…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New hope for advanced gallbladder cancer: drug combo enters trial
Disease control Recruiting nowThis study tests a new drug called ZG005 combined with standard chemotherapy (gemcitabine and cisplatin) as a first treatment for people with advanced gallbladder cancer. About 60 participants will receive the combination to see if it shrinks tumors and how safe it is. The goal i…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Cancer patients may soon skip clinic trips for home treatment
Symptom relief Recruiting nowThis study tests whether giving cancer treatment at home is preferred over going to a clinic. It involves 27 adults with various cancers in the Florida Panhandle. The goal is to see if home care improves patient satisfaction and is safe.
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 02:18 UTC